Chinook Therapeutics

-$0.61 (-5.02%) As of 7:39 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KDNY and other ETFs, options, and stocks.

About KDNY

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.

CEO
Eric L. Dobmeier
Employees
105
Headquarters
Seattle, Washington
Founded
2000

KDNY Key Statistics

Market Cap
516.99M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
193.16K
High Today
$12.14
Low Today
$11.48
Open Price
$12.10
Volume
97.88K
52 Week High
$21.68
52 Week Low
$10.95

KDNY Earnings

-$1.24
-$0.83
-$0.41
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure